Resistance of Cancer Cells to CTL-mediated Immunotherapy
This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help…
Mehr
CHF 197.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V301:
Libri-Titel folgt in ca. 2 Arbeitstagen
Produktdetails
Weitere Autoren: Chouaib, Salem (Hrsg.)
- ISBN: 978-3-319-17806-6
- EAN: 9783319178066
- Produktnummer: 17848257
- Verlag: Springer-Verlag GmbH
- Sprache: Englisch
- Erscheinungsjahr: 2015
- Seitenangabe: 353 S.
- Masse: H24.1 cm x B16.0 cm x D2.5 cm 717 g
- Abbildungen: Book; 11 schwarz-weiße und 27 farbige Abbildungen, 4 schwarz-weiße Tabellen, Bibliographie
- Gewicht: 717
Über den Autor
Benjamin Bonavida, Ph.D., is Professor, UCLA David Geffen School of Medicine for the Department of Microbiology, Immunology & Molecular Genetics. He is also Member, Department of Defense Congressionally Directed Medical Research Program, Member, National Cancer Institute SPORE Program, Member, International Scientific Advisory Board of the Israel Cancer Research Foundation, among other accomplishments. He is currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals. He has published over 450 papers and reviews, has received more than 7,980 citations, and has edited four Springer volumes. Salem Chouaib, Ph.D., is Head, Cancer Immunology Division at Institut Gustave Roussy. His research focuses on augmenting cytotoxic T cell immunity and studies how tumors evade the immune system. Dr. Chouaib has published more than 239 scientific papers and reviews, and has received more than 5,490 citations.
34 weitere Werke von Benjamin (Hrsg.) Bonavida:
Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders
Ebook (EPUB Format)
CHF 169.00
Bewertungen
Anmelden